Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor
Clinical trial NCT07660666 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07660666
- Sponsor
- OHSU Knight Cancer Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2029-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.